Home Biosimilar Antibodies Others Others null Nipocalimab (Anti-FcRn) (FCGRT & B2M) For research use only.
Not for use in humans.

Nipocalimab (Anti-FcRn) (FCGRT & B2M)

Synonyms: M281

Nipocalimab (anti-FcRn) (FCGRT & B2M) is a fully human monoclonal antibody that targets the neonatal crystallizable fragment receptor (FcRn) with potential immunomodulating activity. MW: 142.12 KD.

Nipocalimab (Anti-FcRn) (FCGRT & B2M)

Purity & Quality Control

Batch: A294801 Purity: 99% Protein concentration: 6.24mg/ml Endotoxin Level: ＜1EU/mg
99

Biological Activity

Description Nipocalimab (anti-FcRn) (FCGRT & B2M) is a fully human monoclonal antibody that targets the neonatal crystallizable fragment receptor (FcRn) with potential immunomodulating activity. MW: 142.12 KD.

Product Details

CAS No. 2211985-36-1
Molecular Weight 142.12
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Nipocalimab (Anti-FcRn) (FCGRT & B2M) | Nipocalimab (Anti-FcRn) (FCGRT & B2M) supplier | purchase Nipocalimab (Anti-FcRn) (FCGRT & B2M) | Nipocalimab (Anti-FcRn) (FCGRT & B2M) cost | Nipocalimab (Anti-FcRn) (FCGRT & B2M) manufacturer | order Nipocalimab (Anti-FcRn) (FCGRT & B2M) | Nipocalimab (Anti-FcRn) (FCGRT & B2M) distributor